Arsenal Biosciences, Inc. vs OncoPep, Inc.

Arsenal Biosciences, Inc. logo

Arsenal Biosciences, Inc.

178 employees · est. 2019 · South San Francisco, United...

VS
OncoPep, Inc. logo

OncoPep, Inc.

To develop and commercialize targeted immuno-therapeutics which prevent the progression of cancer and prolong survival

4 employees · est. 2010 · Boston, United States

OncoPep, Inc. is the older company (2019 vs 2010); Arsenal Biosciences, Inc. is the larger of the two.

Side-by-Side Comparison

Arsenal Biosciences, Inc. OncoPep, Inc.
Founded
2019 2010 older
Headquarters
South San Francisco, United States Boston, United States
Employees
178 larger 4
Industry
Biotechnology, Computing, Life Sciences Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series B Series D
Total Funding
$305.81M $28.44M
Funding Rounds
2 6
Services
Development of programmable cell therapies, Research on solid tumor cell therapies, Collaboration with pharmaceutical companies, Engineering of medicines targeting cancer Not tracked yet
Target Customers
Cancer patients, Healthcare providers, Biotechnology researchers, Pharmaceutical collaborators Not tracked yet
Taxonomy
Not tracked yet Immuno-therapeuticsCancer TreatmentMulti-peptide VaccineT Cell TherapyImmunotherapeuticsImmunotherapy +4
Website
arsenalbio.com oncopep.com
Arsenal Biosciences, Inc. logo

About Arsenal Biosciences, Inc.

Arsenal Biosciences, Inc. is a pioneering clinical-stage company specializing in programmable cell therapy, aimed at advancing treatments for solid tumors. Since its founding in 2019, ArsenalBio is leveraging cutting-edge technologies, including precise CRISPR-enabled genome editing and integrated c...

OncoPep, Inc. logo

About OncoPep, Inc.

OncoPep, Inc. is a US-based biotechnology company founded in 2010, with a focus on developing and commercializing targeted immuno-therapeutics to prevent the progression of cancer and prolong survival. The company's slogan emphasizes their commitment to this mission. OncoPep's innovative approach in...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Arsenal Biosciences, Inc. and OncoPep, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Arsenal Biosciences, Inc. or OncoPep, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Arsenal Biosciences, Inc. was founded in 2019, based in South San Francisco, United States, with 178 employees. Arsenal Biosciences, Inc. is a pioneering clinical-stage company specializing in programmable cell therapy, aimed at advancing treatments for solid tumors. Since its founding in 2019, ArsenalBio is le. OncoPep, Inc. was founded in 2010, based in Boston, United States, with 4 employees. OncoPep, Inc. is a US-based biotechnology company founded in 2010, with a focus on developing and commercializing targeted immuno-therapeutics to prevent the progression of cancer and prolong survival.
Arsenal Biosciences, Inc. has raised $305.81M and OncoPep, Inc. $28.44M. Latest stage: Arsenal Biosciences, Inc. Series B, OncoPep, Inc. Series D.
Both work in Biotechnology.

Compare Arsenal Biosciences, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Arsenal Biosciences, Inc. on 3 Jul 2026, and OncoPep, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes